Beachbody (NASDAQ:BODI – Get Free Report) announced its earnings results on Monday. The company reported $0.11 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $49.61 million for the quarter. Beachbody had a return on equity of 46.94% and a net margin of 5.68%.
Here are the key takeaways from Beachbody’s conference call:
- Profitability continued to improve: Q2 revenue of $49.6 million exceeded the midpoint of guidance, while net income reached $1.4 million and adjusted EBITDA was $6.7 million, marking the fourth consecutive quarter of positive net income and the 11th consecutive quarter of positive adjusted EBITDA.
- The company is accelerating its nutrition-led, multi-channel strategy. Shakeology expanded to 131 Sprouts stores with reorders, launched in 481 Vitamin Shoppe locations, and P90X supplements recently became available on Amazon, while energy drinks are scheduled for a Southern California test market in late Q3 or Q4.
- Revenue remains under pressure during the transition away from the legacy MLM model. Q2 revenue declined 22.4% year over year to $49.6 million, digital subscribers fell 19.1% to 760,000, and free cash flow was negative $5.7 million for the first six months due primarily to inventory investment and declining deferred revenue.
- Management guided for Q3 revenue of $44 million to $48 million, net income between a $3 million loss and breakeven, and adjusted EBITDA of $3 million to $6 million. Executives expect Shopify optimization, lower-cost nutrition customer acquisition, retail expansion, Amazon sales, and upcoming fitness launches to begin contributing more meaningfully in late 2026 and into 2027.
Beachbody Stock Performance
Shares of NASDAQ:BODI traded up $0.25 during mid-day trading on Wednesday, reaching $6.54. 96,993 shares of the company traded hands, compared to its average volume of 55,316. The company’s 50 day moving average price is $10.11 and its 200-day moving average price is $10.67. The firm has a market cap of $47.36 million, a PE ratio of 4.01 and a beta of 1.02. Beachbody has a 52 week low of $4.05 and a 52 week high of $16.87. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.76 and a quick ratio of 0.64.
Hedge Funds Weigh In On Beachbody
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on BODI shares. Noble Financial reissued an “outperform” rating on shares of Beachbody in a report on Wednesday, May 13th. Weiss Ratings raised shares of Beachbody from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, June 11th. Zacks Research downgraded shares of Beachbody from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Roth Capital reiterated a “neutral” rating and set a $9.00 price target on shares of Beachbody in a research note on Tuesday. Finally, Canaccord Genuity Group upped their price objective on Beachbody from $15.00 to $19.00 and gave the stock a “buy” rating in a research note on Tuesday, May 5th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $14.33.
Get Our Latest Stock Analysis on BODI
About Beachbody
Beachbody is a consumer-oriented health and fitness company based in Santa Monica, California. Founded in 1998 by Carl Daikeler and Jon Congdon, the company originally gained prominence through at-home workout programs distributed on DVD. Over time, Beachbody has transitioned much of its content delivery to a subscription-based digital platform, offering on-demand streaming of exercise routines, meal plans and wellness coaching.
The company’s portfolio includes a range of branded fitness programs—such as P90X, Insanity, 21 Day Fix and Body Beast—alongside nutrition and supplement products marketed under the Beachbody Nutrition brand.
Featured Stories
- Five stocks we like better than Beachbody
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Beachbody Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beachbody and related companies with MarketBeat.com's FREE daily email newsletter.
